Lyons
France
43
2020-05-07
43
2022-11-15
These are the the leading inventors for applications assigned to Sanofi Pasteur SA:
Sanofi Pasteur SA based in Lyons, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Liquid feeding device for the generation of droplets
#2 | 2020-04-16 β Patent 11,512,898 granted on 2022-11-29Heating device for rotary drum freeze-dryer
#3 | 2020-04-09 β Patent 11,578,917 granted on 2023-02-14Process line for the production of freeze-dried particles
#4 | 2018-02-08 β Patent 10,137,145 granted on 2018-11-27Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#5 | 2017-12-21 β Patent 11,554,170 granted on 2023-01-17Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
#6 | 2017-08-03 β Patent 10,533,800 granted on 2020-01-14Liquid feeding device for the generation of droplets
#7 | 2016-08-18 β Patent 9,878,028 granted on 2018-01-30Process for stabilizing an adjuvant containing vaccine composition
#8 | 2016-02-18 β Patent 9,669,052 granted on 2017-06-06Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#9 | 2015-08-06 β Patent 9,750,800 granted on 2017-09-05Method for purifying the rabies virus
#10 | 2015-01-08 β Patent 10,451,345 granted on 2019-10-22Heating device for rotary drum freeze-dryer
#11 | 2014-12-25 β Patent 9,347,707 granted on 2016-05-24Rotary drum for use in a vacuum freeze-dryer
#12 | 2014-09-04 β Patent 9,920,989 granted on 2018-03-20Process line for the production of freeze-dried particles
#13 | 2014-08-28 β Patent 10,527,350 granted on 2020-01-07Process line for the production of freeze-dried particles
#14 | 2014-08-21 β Patent 10,006,706 granted on 2018-06-26Process line for the production of freeze-dried particles
#15 | 2014-08-07 β Patent 10,143,741 granted on 2018-12-04Immunization compositions and methods
#16 | 2014-06-05 β Patent 9,295,721 granted on 2016-03-29Process for stabilizing an adjuvant containing vaccine composition
#17 | 2014-02-06 β Patent 9,028,839 granted on 2015-05-12Stabilizing excipient for inactivated whole virus vaccine
#18 | 2013-12-26 β Patent 9,327,021 granted on 2016-05-03Immunogenic compositions
#19 | 2011-12-15 β Patent 8,420,805 granted on 2013-04-16Process for preparing prophyrin derivatives, such as protoprophyrin (IX) and synthesis intermediates
#20 | 2011-08-25 β Patent 8,227,587 granted on 2012-07-24Dengue chimeric viruses
#21 | 2011-08-04 β Patent 8,697,353 granted on 2014-04-15Immunization compositions and methods
#22 | 2011-06-23 β Patent 9,145,543 granted on 2015-09-29Process for culturing adherent cells
#23 | 2011-05-19 β Patent 8,029,798 granted on 2011-10-04Multivalent vaccine composition with mixed carrier
#24 | 2011-04-07 β Patent 8,557,253 granted on 2013-10-15Stabilizing excipient for inactivated whole virus vaccine
#25 | 2011-03-03 β Patent 8,338,137 granted on 2012-12-25Type 5 and type 8 capsular polysaccharides of overproducing strains
#26 | 2011-01-20 β Patent 8,506,971 granted on 2013-08-13Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria
#27 | 2011-01-13 β Patent 8,377,682 granted on 2013-02-19System for the heterologous expression of a viral protein in a ciliate host cell
#28 | 2011-01-04 β Patent 7,862,823 granted on 2011-01-04Multivalent vaccine composition with mixed carrier
#29 | 2010-12-30 β Patent 8,557,537 granted on 2013-10-15Method for the production of overproducing strains
#30 | 2010-12-30 β Patent 9,132,181 granted on 2015-09-15Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#31 | 2010-10-14 β Patent 8,961,997 granted on 2015-02-24Method for purifying the rabies virus
#32 | 2010-08-26 β Patent 7,968,102 granted on 2011-06-28Dengue chimeric viruses
#33 | 2009-09-17 β Patent 8,551,527 granted on 2013-10-08Process for stabilizing an adjuvant containing vaccine composition
#34 | 2009-04-09 β Patent 9,005,623 granted on 2015-04-14Flu virus hemagglutinin specific monoclonal antibodies
#35 | 2009-03-26 β Patent 7,871,807 granted on 2011-01-18Method for producing the flu virus
#36 | 2009-01-22 β Patent 8,016,120 granted on 2011-09-13Method for purifying a viral suspension
#37 | 2009-01-15 β Patent 8,673,617 granted on 2014-03-18Culture medium for type B
#38 | 2008-10-02 β Patent 8,026,358 granted on 2011-09-27Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediates
#39 | 2008-06-05 β Patent 7,718,359 granted on 2010-05-18Method of immunization against the 4 serotypes of dengue fever
#40 | 2008-04-10 β Patent 7,718,358 granted on 2010-05-18Method of immunization against the 4 dengue serotypes
#41 | 2008-01-17 β Patent 7,718,357 granted on 2010-05-18Method of immunization against the 4 dengue serotypes
#42 | 2007-08-16 β Patent 9,504,659 granted on 2016-11-29Thermoreversible oil-in-water emulsion
#43 | 2007-02-08 β Patent 7,863,013 granted on 2011-01-04Method for the production of overproducing strains
Also check out Sanofi Pasteur SA's (Lyons, France) applicant profile with 12 patent applications submitted.
355387 β